Hi!

Our roundtables are driven directly by members who bring deep knowledge and passion to key areas of biopharma communications.

The next roundtable we're launching (today!) focuses on investor relations.

IR is a complex discipline in and of itself, though we often find that this is one of many hats we wear as modern-day biopharma communicators.

Which is why we’re looking for five comms/IR pros to help distill the complexity of this topic for the rest of the T2B community!

Everything you need to know about the T2B Investor Relations Roundtable

Together with roundtable chair Ami Bavishi, this group will create programming and resources for the rest of the T2B community, equipping them with the tools they need to enhance trust, credibility, and effective communication with the IR community and beyond.

Through open, honest dialogue, and regular ideas sharing, this roundtable will:

• Facilitate knowledge-sharing to effectively engage investors, analysts, and other key stakeholders amid global market dynamics.
• Develop frameworks for integrating IR into corporate communications, ensuring consistent and cohesive messaging.
• Align evolving corporate affairs priorities with IR considerations spanning crisis communications, critical data readouts, ESG reporting, and expanding investor bases.
• Strengthen T2B’s programming with IR-focused resources and connections that address real-world challenges and opportunities.

“I am excited to lead the Investor Relations Roundtable for T2B as the IR role continues to evolve in our industry amidst the ever-changing global markets. “I hope that the roundtable will be able to share our collective knowledge and experiences to develop relevant and important IR resources and guides, such as aligning IR with corporate communications, as well as brainstorm how to more effectively engage with the broader Wall Street community.” Ami Bavishi, Managing Director, Gilmartin Group LLC

Who can apply for the Investor Relations Roundtable?

Anyone who’s a T2B Pro member can apply for one of the spots for this year’s Investor Relations Roundtable.

However, T2B Pro membership does not guarantee a spot – only five spaces are available.

Applicants must have:

• A basic understanding of and experience in biopharma investor relations with current or prior experience on the agency, corporate (in-house), or consulting side.
• The ability to volunteer 3-5 hours/month to co-create quarterly IR events and monthly resources for the broader T2B community.
• The commitment to actively participate in quarterly roundtable meetings as well as contribute ideas and feedback.
• An active T2B Pro membership.

Ready to Apply? Here’s How!

If you’re a T2B Pro member, you can apply via the form at the following link:

​Applications are now open! ​

Lynnea

​

P.S: If you’d like to be considered for the Investor Relations Roundtable but haven’t yet upgraded to a T2B Pro membership, you can do so here:

​Sign up for T2B Pro​

​
​

​

​